CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Cash flows from operating activities
Net loss	$ (1,376,253)	$ (1,940,907)	$ (3,735,321)	$ (3,955,086)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount and equity issuance costs	185,460	72,516	253,790	138,837
Depreciation and amortization			198,988	65,409
Amortization of loan origination fees				(4,973)
Loss on extinguishment of debt		48,908		1,186,336
Non-cash lease expense			206,900	50,328
Bad debt expense			(21,163)	128,491
Loss on disposal of property and equipment			2,967	5,183
Loss (gain) on warrant derivative liability	(102,761)	4,541	1,095,983	(1,371,079)
Stock-based compensation			62,284	1,006,939
(Gain) loss on sale of assets		(82)	1,467	(139,187)
Changes in operating assets and liabilities, net of acquisitions
Accounts receivable			(175,676)	(344)
Prepaid expenses and other assets			529,224	107,115
Inventories			(219,184)	32,792
Accounts payable and accrued liabilities			(712,362)	(414,877)
Operating lease liabilities			(185,401)	(45,000)
Income taxes				40,535
Net cash used in operating activities:			(2,698,972)	(3,168,581)
Cash flows from investing activities
Purchase of property and equipment			(327,805)	(79,427)
Proceeds from sale of investment			208,761
Proceeds on notes receivable			433,393
Proceeds from sale of building				1,421,134
Net cash provided by investing activities			314,349	1,341,707
Cash flows from financing activities
Proceeds from the sale of common stock and warrants - accrued stock payable				2,185,000
Proceeds from the exercise of warrants				90,000
Proceeds from exercise of stock options			181,709
Proceeds from notes payable			3,960,000	1,500,000
Payments on notes payable			(200,000)	(975,000)
Net cash provided by financing activities			3,941,709	2,800,000
Net increase in cash and cash equivalents			1,557,086	973,126
Cash and cash equivalents, beginning of period			755,769	224,994	$ 224,994
Cash and cash equivalents, end of period	$ 2,312,855	$ 1,198,120	2,312,855	1,198,120	$ 755,769
Supplemental schedule of cash flow information
Cash paid for interest			14,266	273,167
Non-cash investing & financing activities
Cashless warrant exercises			1,557,078	903,779
Beneficial conversion feature			1,110,039	233,500
Issuance of common stock to a consultant			100,000
Deemed dividend from 8.5% warrant repricing				98,000
Operating lease right-of-use asset/operating lease liability				2,721,069
Debt converted to equity				957,056
Issuance of common stock to an employee				100,000
Stock issued in connection with SevenFive Farm acquisition				2,861,495
10% Warrants
Non-cash investing & financing activities
Warrants recorded as a debt discount and additional paid-in capital			$ 1,239,300
15% Warrants
Non-cash investing & financing activities
Warrants recorded as a debt discount and additional paid-in capital				167,163
Warrants recorded as a loss on extinguishment of debt and additional paid-in capital				$ 668,336